Parallel evaluation of doxorubicin‐induced genetic damage in human lymphocytes and sperm using the comet assay and spectral karyotyping
Mutagenesis vol. 19 no. 4 pp. 313±318, 2004
DOI: 10.1093/mutage/geh032
Parallel evaluation of doxorubicin-induced genetic damage in human
lymphocytes and sperm using the comet assay and spectral
karyotyping1
A.Baumgartner1,2, T.E.Schmid1,3, E.Cemeli1 and
D.Anderson1,4
1Department of Biomedical Sciences, University of Bradford, Bradford BD7
1DP, UK, 2GSF Research Center, Institute of Molecular Radiobiology,
85764 Neuherberg, Germany and 3School of Public Health, University of
California in Berkeley, Berkeley, CA 94720, USA
In recent years, two techniques for detecting genetic
damage in the whole genome have gained importance: the
alkaline comet assay, to detect DNA damage such as
strand breaks and alkali-labile sites, and a multicolour
FISH method, spectral karyotyping (SKY), to identify
chromosomal aberrations simultaneously in all metaphase
chromosomes. In the present study, the induction of DNA
damage in human sperm and lymphocytes in vitro has
been studied employing an anticancer drug, doxorubicin
(DX). An increase in DNA damage was observed with the
comet assay as the median per cent head DNA of sperm
signi®cantly decreased from 82.07 and 85.14% in the
untreated control groups to 63.48 and 72.52% at doses of
0.8 mM DX. At 1.6 mM the percentage declined to 60.96%
(the corresponding tail moment increased from 4.42 to
12.19). In stimulated lymphocytes, a signi®cant increase
was observed in tail moment, from 0.72 and 0.53 in
controls to 15.17 and 12.10 at 0.2 mM DX, continuing at
the same level to a ®nal concentration of 1.6 mM.
Structural aberrations found in the parallel SKY study in
stimulated lymphocytes at 0.2 mM DX consisted of 14%
chromatid-type and 2% chromosome-type aberrations;
none were found in controls. The SKY results correlate
very well with the ®ndings of the comet assay in lymphocytes where DNA damage was observed at similar doses.
This study is the ®rst reporting use of the comet assay
and SKY analysis in parallel after chemical treatment.
The potential of the two techniques together is evident, as
they represent a set of assays feasible for evaluating
damage in human somatic and germ cells after chemical
treatment (i) by direct observation of two different endpoints, detecting general DNA damage and chromosomal
aberrations and (ii) by extrapolation from lymphocytes to
sperm, which provides a `parallelogram' approach in
human cells.
Introduction
The importance of assessing genotoxicity in human somatic
and germ cells will continue to have an important role in the
future, particularly with concerns about the detrimental effects
on reproduction in terms of male infertility and sperm count
(Medical Research Council, 1995). The single cell gel
electrophoresis (comet) assay has already been extensively
used to detect DNA damage in the whole genome in single
cells as double- and single-strand breaks and alkali-labile sites
(Singh et al., 1988; Anderson et al., 1998). However, a
combination of the comet assay with a multicolour ¯uorescence in situ hybridization (FISH) method, spectral karyotyping (SKY), which detects chromosomal aberrations in all
human metaphase chromosomes simultaneously (SchroÈck
et al., 1996), allows a different type, yet detailed, assessment
of induced damage in the whole genome.
In the comet assay, induced DNA damage is evaluated after
single cell gel electrophoresis by measuring the tail moment as
the product of per cent tail DNA multiplied by the tail length of
the comet and the per cent head DNA. After alkaline lysis,
damaged DNA originating from DNA strand breaks and alkalilabile sites thereby pass out of the nuclei moving towards the
anode along the electrical ®eld and form comet-like structures
(Tice et al., 2000; Olive, 2002). In contrast, with SKY, speci®c
chromosomal damage can be evaluated, for numerical and
structural aberrations in all 46 human chromosomes simultaneously by employing FISH with DNA probes labelled with a
combination of ®ve different ¯uorochromes. Thus, each
chromosome has a unique ¯uorescence spectrum, enabling
computer software to classify all 24 different human chromosomes (22 pairs plus X and Y) ef®ciently. The threshold for
detecting translocation fragments is ~10±20 Mb (Gray and
Collins, 2000; Wang et al., 2002). In contrast to classical
methods of chromosome aberration detection, where Giemsa
banding (see for example Ronne, 1990) has mainly been used,
SKY is able to detect hidden aberrations and uncharacterized
marker chromosomes throughout the whole genome by evaluating all chromosomes from their distinct colour (Mohr et al.,
2000).
When cancer has been diagnosed in a patient, various
treatments using multiple combinations of chemotherapeutic
agents are possible, depending on the type of cancer. Some of
these anticancer agents speci®cally act on dividing cells during
mitosis by inhibiting cell division (reviewed in Stewart et al.,
2003), while others act non-speci®cally (reviewed in
Blagosklonny, 2003). As a consequence, they cause apoptosis
and/or necrosis, subsequently leading to cell death.
Proliferating cells are more likely to die as a result of the
damage induced, but cells surviving the exposure may carry
mutations and chromosomal aberrations. To evaluate the
combination of comet and SKY in human somatic and germ
cells, doxorubicin (DX), a well-known anticancer drug, was
employed. DX, formerly known as adriamycin, is an
anthracycline antibiotic produced by the fungus Streptomyces
peucetius. DX treatment at therapeutic doses leads to the
induction of CD95-ligand (CD95-L). CD95-L can mediate cell
death (apoptosis) by cross-linking the CD95 receptor (CD95)
(Friesen et al., 1999). DX is also able to inhibit reverse
transcriptase (Tomita and Kuwata, 1976) and RNA synthesis
(Li and Yu, 1993). However, at the DNA level, three major
mechanisms of action have been identi®ed for DX (Cummings
4To whom correspondence should be addressed. Tel: +44 1274 23 3569; Fax: +44 1274 30 9742; Email:
Mutagenesis vol. 19 no. 4 ã UK Environmental Mutagen Society 2004; all rights reserved.
313
A.Baumgartner et al.
et al., 1991): binding DNA effectively by intercalation of the
anthracycline portion; causing DNA damage via the production
of free radicals from reactive oxygen species (ROS); stabilizing the topoisomerase II cleavage complex, which is critical for
DNA function. As a consequence of these multiple effects,
single- and double-strand breaks are introduced into the DNA
(Cummings et al., 1991). It was shown that DX induces
chromosome aberrations in murine bone marrow cells and in
spermatocytes and that chromosome aberrations were sustained in the surviving spermatogonial cells (Au and Hsu,
1980). DX also increased the frequency of meiotic micronuclei
in male rats (Laehdetie et al., 1983), which showed impaired
fertility after being treated. Decreased weights of the genital
organs, an extremely decreased number of sperm, low sperm
motility, a low implantation rate and a decreased number of
live foet (...truncated)